ArticleProceedings of the National Academy of Sciences of the United States of America2021

Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic.

Iñaki Etxeberria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.